• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童急性白血病患者接受白消安或全身照射造血干细胞移植后长期效应的发生:AIEOP(意大利儿科血液学肿瘤学会)回顾性研究的结果。

Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study.

机构信息

Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy.

University of Turin, Turin, Italy.

出版信息

Bone Marrow Transplant. 2020 Oct;55(10):1918-1927. doi: 10.1038/s41409-020-0806-8. Epub 2020 Jan 29.

DOI:10.1038/s41409-020-0806-8
PMID:31996791
Abstract

Patients given allogeneic hematopoietic stem cell transplantation (alloHSCT) present an increased incidence of long-term toxicities that can be attributed to the preparative regimen. We retrospectively analyzed in a population of 670 children receiving allo-HSCT for acute leukemia the occurrence of different late effects in function of the choice made between total body irradiation (TBI) and busulfan, as part of the preparative regimen. In univariable analysis, we found that patients treated with TBI developed cataract in 24% of the cases compared with 4% in patients treated with BU (p = 0.0001) and that the incidence of secondary malignant neoplasia (SMN) was higher in patients treated with TBI (18%) as compared with those prepared to the allograft with a Bu-based regimen (0%) (p = 0.019). Conditioning regimen did not show a statistically significant correlation with the occurrence of all the other investigated late effects. In multivariable analysis, TBI remained associated with the occurrence of cataracts (Relative Risk: 0.33 p = 0.012) and secondary malignancies (Relative Risk 3.96 × 10e-6 p < 0.001); however, other variables, as GvHD and disease type, were also correlated with these long-term sequels, indicating that in our study population the preparative regimen is not the only factor influencing the incidence of these complications.

摘要

接受异基因造血干细胞移植(alloHSCT)的患者会出现长期毒性的发生率增加,这可归因于预处理方案。我们回顾性分析了 670 名接受 allo-HSCT 治疗急性白血病的儿童人群,根据全身照射(TBI)和白消安(BU)作为预处理方案的选择,分析了不同迟发性效应的发生情况。单变量分析发现,接受 TBI 治疗的患者中有 24%发生白内障,而接受 BU 治疗的患者中只有 4%(p=0.0001),并且接受 TBI 治疗的患者发生继发性恶性肿瘤(SMN)的发生率高于接受 BU 为基础的方案预处理的患者(0%)(p=0.019)。预处理方案与所有其他研究的迟发性效应的发生之间没有统计学上的显著相关性。多变量分析表明,TBI 仍然与白内障(相对风险:0.33,p=0.012)和继发性恶性肿瘤(相对风险 3.96×10e-6,p<0.001)的发生相关;然而,其他变量,如 GvHD 和疾病类型,也与这些长期后遗症相关,这表明在我们的研究人群中,预处理方案并不是影响这些并发症发生率的唯一因素。

相似文献

1
Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study.儿童急性白血病患者接受白消安或全身照射造血干细胞移植后长期效应的发生:AIEOP(意大利儿科血液学肿瘤学会)回顾性研究的结果。
Bone Marrow Transplant. 2020 Oct;55(10):1918-1927. doi: 10.1038/s41409-020-0806-8. Epub 2020 Jan 29.
2
Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study.异基因造血干细胞移植后儿童急性白血病或骨髓增生异常综合征患者应用噻替哌或白消安为基础预处理方案的长期并发症:意大利儿科血液病学和肿瘤学学会的一项回顾性研究结果。
Transplant Cell Ther. 2024 Apr;30(4):433.e1-433.e10. doi: 10.1016/j.jtct.2023.12.671. Epub 2024 Jan 2.
3
Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis.白血病患者造血干细胞移植前,环磷酰胺加全身照射与白消安加环磷酰胺作为预处理方案的比较:一项系统评价和荟萃分析。
Hematol Oncol Stem Cell Ther. 2011;4(1):17-29. doi: 10.5144/1658-3876.2011.17.
4
Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.全身照射及环磷酰胺加抗胸腺细胞球蛋白方案耐受性良好,并且作为急性白血病T细胞充足的单倍体相合移植前的预处理方案,可促进稳定植入。
Biol Blood Marrow Transplant. 2014 Aug;20(8):1176-82. doi: 10.1016/j.bbmt.2014.04.012. Epub 2014 Apr 18.
5
Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.环磷酰胺联合全身照射、口服白消安或静脉注射白消安用于成人急性淋巴细胞白血病异基因造血细胞移植的比较
Biol Blood Marrow Transplant. 2016 Dec;22(12):2194-2200. doi: 10.1016/j.bbmt.2016.09.007. Epub 2016 Sep 13.
6
Irradiation free conditioning regimen is associated with high relapse rate in Egyptian patients with acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation.在接受异基因造血干细胞移植后,埃及急性淋巴细胞白血病患者的无辐射预处理方案与高复发率相关。
J Egypt Natl Canc Inst. 2020 Jun 15;32(1):28. doi: 10.1186/s43046-020-00042-4.
7
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.缓解期急性髓系白血病的异基因造血干细胞移植:静脉用白消安加环磷酰胺(Cy)与全身照射加 Cy 作为预处理方案的比较——欧洲血液和骨髓移植学会急性白血病工作组的报告。
J Clin Oncol. 2013 Oct 1;31(28):3549-56. doi: 10.1200/JCO.2013.48.8114. Epub 2013 Aug 26.
8
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.白消安与全身照射相比,慢性移植物抗宿主病、闭塞性细支气管炎和脱发的风险增加:白血病异基因骨髓受者随机试验的长期结果。北欧骨髓移植组
Blood. 1999 Apr 1;93(7):2196-201.
9
Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.全身照射联合环磷酰胺与白消安联合环磷酰胺作为急性淋巴细胞白血病预处理方案的长期疗效比较:一项对照研究。
Ann Hematol. 2018 Oct;97(10):1987-1994. doi: 10.1007/s00277-018-3383-9. Epub 2018 Jun 5.
10
Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.骨髓移植的肺部并发症:全身照射与环磷酰胺联合白消安与环磷酰胺的比较
Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):69-73. doi: 10.1016/0360-3016(94)00541-R.

引用本文的文献

1
Comparable outcomes for pediatric acute lymphoblastic leukemia patients receiving conditioning with total body irradiation or chemotherapy: A nationwide, Korean registry-based study.接受全身照射或化疗预处理的儿童急性淋巴细胞白血病患者的可比结局:一项基于韩国全国登记处的研究。
Hemasphere. 2025 Jun 17;9(6):e70158. doi: 10.1002/hem3.70158. eCollection 2025 Jun.
2
Long-Term Outcomes of Reduced-Toxicity Conditioning Using 8-Gray Total Body Irradiation, Fludarabine, and Cyclophosphamide in Children, Adolescents, and Young Adults With Hematological Malignancies.采用8格雷全身照射、氟达拉滨和环磷酰胺进行低毒性预处理对血液系统恶性肿瘤儿童、青少年和青年成人的长期疗效
Hematol Oncol. 2025 Jan;43(1):e70026. doi: 10.1002/hon.70026.
3

本文引用的文献

1
1994 Consensus Conference on Acute GVHD Grading.1994年急性移植物抗宿主病分级共识会议。
Bone Marrow Transplant. 1995 Jun;15(6):825-8.
Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia.
儿童急性淋巴细胞白血病中采用白消安、氟达拉滨和依托泊苷靶向预处理方案进行异基因造血干细胞移植的前瞻性II期研究
Hemasphere. 2024 Nov 28;8(12):e70051. doi: 10.1002/hem3.70051. eCollection 2024 Dec.
4
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM.基于白消安或苏消安预处理方案的儿童急性淋巴细胞白血病异基因造血干细胞移植的可比结局:FORUM研究结果
Blood Adv. 2025 Feb 25;9(4):741-751. doi: 10.1182/bloodadvances.2024014548.
5
How I treat sickle cell disease with gene therapy.我如何用基因疗法治疗镰状细胞病。
Blood. 2024 Dec 26;144(26):2693-2705. doi: 10.1182/blood.2024024519.
6
TBI/Cy followed by auto-HSCT is a good choice next to allo-HSCT for patients with T-LBL/ALL.TBI/Cy 序贯自体外周血造血干细胞移植是 T-LBL/ALL 患者异基因造血干细胞移植之外的另一种较好选择。
Sci Rep. 2024 Sep 27;14(1):22356. doi: 10.1038/s41598-024-72897-9.
7
Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen.对于高危、首次复发的B细胞急性淋巴细胞白血病儿童,无论预处理方案如何,与化疗相比,博纳吐单抗与更好的移植后结局相关。
Haematologica. 2025 Jan 1;110(1):234-238. doi: 10.3324/haematol.2024.285837.
8
Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial.记忆 T 细胞富集的半相合 NK 细胞回输移植具有良好的长期疗效:一项 II 期临床试验。
J Hematol Oncol. 2024 Jun 27;17(1):50. doi: 10.1186/s13045-024-01567-0.
9
Evolution of dosimetric treatment planning for pediatric total lymphoid irradiation (TLI): a single-institution experience.儿童全淋巴照射(TLI)剂量学治疗计划的演变:单机构经验
Rep Pract Oncol Radiother. 2024 Feb 16;28(6):772-783. doi: 10.5603/rpor.98734. eCollection 2023.
10
Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.儿童、青少年和青年癌症幸存者肺功能障碍监测建议:国际儿童癌症长期效应指南协调小组报告
EClinicalMedicine. 2024 Feb 20;69:102487. doi: 10.1016/j.eclinm.2024.102487. eCollection 2024 Mar.